Stories And News

Events

ASH Annual Meeting 2022 – Research and insight summary

ASH Annual Meeting 2022 – summary and key take-outs By Dr Zoe Drymoussi During the 9-12th December 2022, the FLF team attended, in person, for

January 26, 2023

Articles

Looking back over the last 25 years for FL – the Rituximab era

Looking back over the last 25 years for FL – the Rituximab era By Dr Mitchell Smith, Chief Medical Officer A recent re-publication marking 25

January 25, 2023

Articles

Research in focus: Bi-specific antibodies approval.

Research in focus: Bi-specific antibodies approval. By Dr. Zoe Drymoussi Over the last few years, a promising new class of treatments for advanced-stage FL has

December 14, 2022

Events

FLF are attending the ASH 2022 Annual Meeting

FLF are attending the ASH 2022 Annual Meeting We are delighted that some of the team are able to attend the 64th ASH Annual Meeting

December 6, 2022

Announcements

CURE FL Awards. Funding $2m of targeted, innovative, patient driven research

New funding of $2 million for research to get one step closer to a cure for Follicular Lymphoma. Our mission at the FLF is to

November 28, 2022

Fundraising

A big thank-you to all at Henry and Esther’s Golden Anniversary celebration

Henry and Esther Shirman, two supporters that have been with the FLF since day one, recently celebrated their 50th wedding anniversary, and they certainly did

November 8, 2022

Fundraising

The fabulous kindness of the Snowdown Colliery Welfare Brass Band

The wonderful Snowdown Colliery Welfare Brass Band recently (October 8th) created a fabulous afternoon of music for the local community of Dover, Kent. The band

November 8, 2022

Announcements

Kate Rogers our new CEO

Kate Rogers joins from her previous role at GSK plc as Global Finance Transformation Lead at GSK. She also continues to serves as Non-Executive Director

July 15, 2022

Announcing: New funding of $2 million for research to get one step closer to a cure for Follicular Lymphoma.